Search Results 4951-4960 of 38404 for oral

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  3. Arthritis - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgeon. Rochester, MN. Areas of focus: Minimally invasive surgery, Trauma care, Joint replacement surgery, Nerve graft, Nonunion ...

  4. Arthritis - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgeon. Rochester, MN. Areas of focus: Minimally invasive surgery, Trauma care, Joint replacement surgery, Nerve graft, Nonunion ...

  5. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer - Mayo Clinic

    Subjects on full-dose anticoagulation must be on a stable dose of oral anticoagulant or low molecular weight heparin. ... Therapy for potential drug interactions ...

  6. INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes - Mayo Clinic

    ... oral/injectable contraceptives, IUD, or implant); childbearing potential means that menstruation has started, and the participant is not surgically sterile ...

  7. Throat cancer - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Head and neck cancer, Skin cancer, Oropharyngeal cancer, Mouth cancer, Thyroid cancer, Melanoma, Squamous cell carcinoma of the skin ...

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  9. ... years. Oral Cavity & Pharynx. 16.9. 2.8. Kidney & Renal Pelvis. Target. 80.5%. 15.3. 3.6. Pancreas. 14.0. 11.2. Ovary. 12.6. 6.1. Thyroid. 12.1. 0.4. County.

  10. A Study to Evaluate the Effectiveness and Safety of Benralizumab in Patients with Hypereosinophilic Syndrome (HES) - Mayo Clinic

    ... oral, intravaginal, or transdermal 2. Progestogen-only hormonal contraception associated with inhibition of ovulation: oral, injectable, or implantable 3 ...